查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1610019

乳癌近距离放射治疗市场规模、份额、趋势分析报告：按技术、按产品、按地区、细分市场预测，2025-2030 年

Breast Cancer Brachytherapy Market Size, Share & Trends Analysis Report By Technology (HDR, LDR), By Product (Applicators And Afterloaders, Electronic Brachytherapy), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

乳癌近距离治疗市场成长与趋势

Grand View Research, Inc.最新报告显示，预计2030年全球乳癌近距离治疗市场规模将达13亿美元，2025年至2030年复合年增长率为6.9%。乳癌盛行率的增加预计将加速市场成长。例如，根据 Breastcancer.org 的报告，截至 2020 年 1 月，美国有超过 350 万名女性罹患乳癌。

此外，学术医疗中心、肿瘤中心和医院越来越多地采用近距离放射治疗，预计也将促进市场成长。例如，2018年10月，Navicent Health选择了iCAD, Inc.开发的Xoft Axxent电子近距离放射治疗（eBx）系统来治疗乔治亚的乳癌。此外，2018 年 10 月，纽约州立大学上州医科大学选择 Xoft Axxent 电子近距离放射治疗 (eBx) 系统来治疗早期乳癌。

此外，开发中国家的政府医院正在实施先进的系统，为病患提供更优质的照护。例如，2018 年 8 月，Eckert 和 Ziegler BEBIG 在尼泊尔 BP Koirala Memorial 癌症医院交付并安装了 SagiNova HDR后荷机。 SagiNova 适用于间质性乳房植入。因此，医院使用此类近距离放射治疗系统预计将推动市场成长。

市场参与企业参与合作研究和伙伴关係等策略性倡议预计将在未来几年推动需求。例如，2018 年 7 月，RaySearch 与 Eckert 和 Ziegler BEBIG 合作，将 SagiNova 与 RayCare 肿瘤资讯系统和 RayStation 治疗计划系统集成，以改善近距离放射治疗期间的治疗效果。

据估计，医疗中心 HDR 单位机构资助倡议的增加将推动市场发展。例如，2019 年 4 月，OSJ 慈善信託基金与义大利加拿大人全国联合会合作，将 SagiNova 引入 Santo Spirito 医院，作为体外放射治疗的替代方案，以实现有针对性的治疗和更快的治疗时间。

针对肿瘤科医生、外科医生和医院的有利报销政策预计将推动市场成长。例如，根据医疗保险和医疗补助服务中心 (CMS) 发布的编码，5 天治疗期的 HDR 近距离放射治疗的医疗保险报销为 11,000 美元。

乳癌近距离放射治疗市场报告亮点

  • HDR 近距离放射治疗预计将在 2024 年占据市场主导地位，并成为预测期内成长最快的技术领域。
  • 快速放射治疗、短时间内精准的肿瘤特异性剂量治疗等因素预计将推动此领域的发展。
  • 由于主要参与企业的存在以及肿瘤中心和医院越来越多地采用该治疗方法，北美将在 2024 年占据市场主导地位。
  • 由于投资者和公司在该地区扩大业务的需求和成长机会未被满足，预计亚太地区的市场在预测期内将快速成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章乳癌近距离放射治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章乳癌近距离治疗市场：技术业务分析

  • 2024年及2030年技术市场占有率
  • 技术细分仪表板
  • 2018-2030 年按技术分類的市场规模、预测与趋势分析
  • HDR（高剂量率）
  • LDR（低剂量率）

第五章乳癌近距离治疗市场：产品业务分析

  • 2024年及2030年产品市场占有率
  • 产品细分仪表板
  • 2018-2030 年按产品分類的市场规模、预测与趋势分析
  • 施用器和后荷机
  • 电子近距离放射治疗
  • 其他的

第六章乳癌近距离治疗市场：技术、产品、区域、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区划分，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • Eckert &Ziegler BEBIG
    • Elekta
    • Varian Medical Systems, Inc.
    • Hologic, Inc.
    • Merit Medical Systems
    • BD
Product Code: GVR-4-68038-953-1

Breast Cancer Brachytherapy Market Growth & Trends:

The global breast cancer brachytherapy market size is estimated to reach USD 1.3 billion by 2030, expanding at a CAGR of 6.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of breast cancer is expected to accelerate market growth. For instance, the Breastcancer.org reported that as of January 2020, there were more than 3.5 million women suffering from breast cancer in the U.S.

In addition, the rising adoption of brachytherapy by academic medical centers, oncology centers, and hospitals is expected to boost the market growth. For instance, in October 2018, Navicent Health adopted the Xoft Axxent Electronic Brachytherapy (eBx) System developed by iCAD, Inc. for the treatment of breast cancer in Georgia. Furthermore, in October 2018, SUNY Upstate Medical University also adopted the Xoft Axxent Electronic Brachytherapy (eBx) System to provide treatment for early-stage breast cancer.

Moreover, government hospitals in developing countries are installing advanced systems to provide better quality treatment for their patients. For instance, in August 2018, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for interstitial breast implants. Hence, the use of such brachytherapy systems by hospitals is expected to fuel market growth.

Market players entering into strategic initiatives such as collaborations and partnerships are anticipated to propel the demand over the next few years. For instance, in July 2018, RaySearch partnered with Eckert and Ziegler BEBIG to integrate SagiNova with the RayCare oncology information system and RayStation treatment planning system to improve treatment outcomes during brachytherapy.

An increase in funding initiatives for HDR units in medical centers by organizations is estimated to drive the market. For instance, in April 2019, OSJ Charities Trust Fund collaborated with the National Federation of Italian Canadians to donate SagiNova for Santo Spirito Hospital as an alternative to external beam radiation therapy for a targeted approach and shorter treatment time.

Favorable reimbursement policies for oncologists, surgeons, and hospitals are expected to fuel market growth. For instance, HDR brachytherapy offers USD 11,000 as Medicare reimbursement for five days treatment period according to the coding issued by Centers for Medicare and Medicaid Services (CMS).

Breast Cancer Brachytherapy Market Report Highlights:

  • HDR brachytherapy dominated the market in 2024 and is also projected to be the fastest-growing technology segment over the forecast period
  • Factors such as rapid delivery of radiation, accuracy, and precise tumor-specific dose delivery in a shorter period of time are expected to drive the segment
  • North America has dominated the market in 2024 owing to the presence of key players and increasing adoption of the therapy by oncology centers and hospitals
  • In Asia Pacific, the market is estimated to grow fast over the forecast period due to high unmet needs and growth opportunities for investors and companies to expand their presence in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Breast Cancer Brachytherapy Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Breast Cancer Brachytherapy Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 4.4. High Dose Rate (HDR)
    • 4.4.1. High Dose Rate (HDR) Market, 2018 - 2030 (USD Million)
  • 4.5. Low Dose Rate (LDR)
    • 4.5.1. Low Dose Rate (LDR) Market, 2018 - 2030 (USD Million)

Chapter 5. Breast Cancer Brachytherapy Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Applicators and Afterloaders
    • 5.4.1. Applicators and Afterloaders Market, 2018 - 2030 (USD Million)
  • 5.5. Electronic Brachytherapy
    • 5.5.1. Electronic Brachytherapy Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Breast Cancer Brachytherapy Market: Regional Estimates & Trend Analysis by Technology and Product

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Breast Cancer Brachytherapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Breast Cancer Brachytherapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Eckert & Ziegler BEBIG
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Elekta
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Varian Medical Systems, Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Hologic, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Merit Medical Systems
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. BD
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global breast cancer brachytherapy market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 6 North America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 8 North America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 12 Canada breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Mexico breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Europe breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 19 UK breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Germany breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 22 France breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Italy breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Spain breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Norway breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 30 Denmark breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Denmark breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Japan breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 39 China breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 40 China breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 41 India breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 42 India breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Australia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 46 South Korea breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Thailand breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 49 Latin America breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Latin America breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Brazil breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Argentina breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Breast cancer brachytherapy market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Africa breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 64 UAE breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait breast cancer brachytherapy market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Kuwait breast cancer brachytherapy market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast cancer brachytherapy market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology and product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Breast cancer brachytherapy market dynamics
  • Fig. 12 Breast cancer brachytherapy market: Porter's five forces analysis
  • Fig. 13 Breast cancer brachytherapy market: PESTLE analysis
  • Fig. 14 Breast cancer brachytherapy market: Technology segment dashboard
  • Fig. 15 Breast cancer brachytherapy market: Technology market share analysis, 2024 & 2030
  • Fig. 16 High dose rate (HDR) market, 2018 - 2030 (USD Million)
  • Fig. 17 Low dose rate (LDR) market, 2018 - 2030 (USD Million)
  • Fig. 18 Breast cancer brachytherapy market: Product segment dashboard
  • Fig. 19 Breast cancer brachytherapy market: Product market share analysis, 2024 & 2030
  • Fig. 20 Applicators and afterloaders market, 2018 - 2030 (USD Million)
  • Fig. 21 Electronic brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Breast cancer brachytherapy market revenue, by region
  • Fig. 24 Regional marketplace: Key takeaways
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 North America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. country dynamics
  • Fig. 28 U.S. breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Canada country dynamics
  • Fig. 30 Canada breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico country dynamics
  • Fig. 32 Mexico breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 33 Europe breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 34 UK country dynamics
  • Fig. 35 UK breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany country dynamics
  • Fig. 37 Germany breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 38 France country dynamics
  • Fig. 39 France breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy country dynamics
  • Fig. 41 Italy breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain country dynamics
  • Fig. 43 Spain breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway country dynamics
  • Fig. 45 Norway breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden country dynamics
  • Fig. 47 Sweden breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark country dynamics
  • Fig. 49 Denmark breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan country dynamics
  • Fig. 52 Japan breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 53 China country dynamics
  • Fig. 54 China breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 55 India country dynamics
  • Fig. 56 India breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 57 Australia country dynamics
  • Fig. 58 Australia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 59 South Korea country dynamics
  • Fig. 60 South Korea breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand country dynamics
  • Fig. 62 Thailand breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil country dynamics
  • Fig. 65 Brazil breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina country dynamics
  • Fig. 67 Argentina breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 68 MEA breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa country dynamics
  • Fig. 70 South Africa breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia country dynamics
  • Fig. 72 Saudi Arabia breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE country dynamics
  • Fig. 74 UAE breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 75 Kuwait country dynamics
  • Fig. 76 Kuwait breast cancer brachytherapy market, 2018 - 2030 (USD Million)
  • Fig. 77 Company categorization
  • Fig. 78 Company market position analysis
  • Fig. 79 Strategic framework